Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressants and the monoamine masquerade.

David Sulzer1, Robert H Edwards

  • 1Department of Neurology, Columbia University, New York State Psychiatric Institute, New York, New York 10032, USA.

Neuron
|April 12, 2005
PubMed
Summary

Elevated serotonin levels cause dopamine neurons to accumulate serotonin, acting as a false transmitter. This finding suggests serotonin release by dopamine neurons may contribute to antidepressant effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered striatal dopamine regulation in Adgrl3 knockout mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

α-Synuclein and γ-Tubulin Cooperatively Regulate Activity-Evoked Presynaptic Microtubule Nucleation to Gate Dopamine Release.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis.

Nature·2026
Same author

Neuromelanin, iron and MRI measurements in midbrain tissues of Parkinson's and Alzheimer's subjects.

Frontiers in aging neuroscience·2026
Same author

α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction.

Science advances·2026
Same author

Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses.

Journal of the American Chemical Society·2025

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Molecular Biology

Background:

  • Neurotransmitter transporters typically recognize related compounds, leading to "false transmitter" accumulation and release.
  • Serotonin (5-HT) and dopamine (DA) are key monoamine neurotransmitters implicated in mood regulation and psychiatric disorders.

Discussion:

  • Zhou et al. demonstrate that elevated serotonin, induced by inhibiting serotonin reuptake or monoamine oxidase, leads to serotonin accumulation within dopamine neurons.
  • This accumulation suggests that dopamine neurons can uptake and process serotonin, functioning similarly to other monoamine systems.

Key Insights:

  • Dopamine neurons actively accumulate serotonin when extracellular serotonin levels are high.
  • Serotonin acts as a "false transmitter" in dopamine neurons under specific pharmacological conditions.
  • This interaction provides a novel mechanism potentially linking serotonin modulation to dopamine neuron activity.

Outlook:

  • The findings suggest a new pathway through which antidepressants, affecting serotonin levels, might influence dopamine signaling.
  • Further research could explore the functional consequences of serotonin release by dopamine neurons on behavior and cognition.
  • Investigating this cross-talk could reveal new therapeutic targets for depression and other mood disorders.

Related Experiment Videos